I will say this about investigation status. Whether there were one or more than one, for whatever reason they were initiated and/or are on-going and regardless of when they began, there definitely is reason for a full-blown investigation to occur at this time. The company is operating in defiance of SEC filing requirements, is not declaring the situs of operations, has broken all lines of communication with shareholders, the makeup of management is a secret and yet there is open trading. See a problem here. Further, it is unknown what if any relevance the NUGX listing has which involves a key component business interest over which the company holds and is supposed to control.
Sorry for the ultra-long sentence.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links